http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015126129-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fd6fdb8cc439061143dc8a966303868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0073d84f3ddee0904f5b58461f1c73a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate 2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553494de13e767eff4a148a9323fe3a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070df71a6350a40aa2540d1dba6d0a79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d694dc754a31686bc6d3a31dca484e
publicationDate 2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015126129-A3
titleOfInvention Resveratrol multimer having selective inhibitory activity for hepatitis c virus genome replication, and use thereof
abstract The present invention relates to a resveratrol multimer having a selective inhibitory activity for hepatitis C virus genome replication, and a use thereof, and more particularly, to a resveratrol multimer having a selective inhibitory activity for hepatitis C virus genome replication, and a pharmaceutical composition for preventing or treating hepatitis C, containing the same. The resveratrol multimer according to the present invention has very low hepatotoxicity and a remarkable effect of selectively inhibiting hepatitis C virus genome replication, and thus is expected to be useful as an active ingredient of a pharmaceutical composition or a nutraceutical composition for preventing, alleviating or treating hepatitis C.
priorityDate 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174

Total number of triples: 23.